The MRCF invests exclusively in opportunities from its Member Institutes. If you are interested in accessing the MRCF and are associated with a Member Institute, please contact your commercialisation office for assistance.
The MRCF is interested in opportunities with milestone-based development programs requiring smaller first round financial commitments to generate further exemplification of the technology. The MRCF has capacity to make follow-on investments of up to $4 million, but will seek co-investment with other investors for technologies with larger capital requirements. The MRCF has the ability to provide financial and strategic management assistance for the further development of technologies.
The investment review process follows four distinct stages:
- Each Member Institute has a representative on the Investment Review Committee (IRC). The Institute representative will present a brief overview of the investment opportunity to the IRC (Preliminary Investment Proposal-PIP).
- If this initial proposal is recommended to progress, a presentation by the key researchers and full investment proposal (Investment Application Form – IAF) will be requested for the next IRC meeting.
- If the IRC is supportive of the technology receiving investment, the opportunity is passed to the Brandon Capital Partners, who completes due diligence on each opportunity.
- If Brandon Capital Partners is supportive of the opportunity, it recommends to the Board that the investment is made. Guidance is provided by Brandon Capital Partners for the preparation of both the initial and full investment proposals. Please see the ‘Contact Us’ page for contact information.
When reviewing a technology, the MRCF looks at the following criteria:
- Whether the technology represents world class science;
- What is required to demonstrate proof-of-concept or reach the next key milestones for the technology;
- Market size and need within the market;
- The competition and competitive edge of the technology;
- The strength of the intellectual property position;
- The key personnel and management; and
- Commercialisation path, likely exit and potential value at exit